Clubs How It Works

Markets Markets News MakklerAI My Portfolio · Pro

Makkler vs. eToro Makkler vs. Skool Makkler vs. YouTube

MakklerPRO About Us

Log In Get Started Free

Overview Stocks Crypto Currencies Commodities ETFs Options My watchlist

Makkler App

Faster and clearer

CRTX News - CRISM Therapeutics Corporation | Makkler

Overview/Stocks/CRTX

CRISM Therapeutics Corporation CRTX

LSE · United Kingdom · Commercial Services

GBp 9.500.00 (0.00%)

Market closed· Oct 1, 2026, 9:37 AM UTC· GBp · Data may be delayed

Overview Financials Analysis Earnings Dividends Technicals Historical data News

Prices may be delayed and are for informational purposes only - not investment advice.

My Portfolio · Pro

Makkler vs. eToro

Makkler vs. Skool

Makkler vs. YouTube

Get Started Free

The portfolio-sharing platform connecting finance content creators with an audience that wants to learn.

Theme

Platform

Clubs Markets Markets News MakklerPRO Makkler Token How It Works Become a Creator

Compare

Makkler vs. eToro Makkler vs. Skool Makkler vs. YouTube

Company

About Us Contact

Legal

Terms of Service Privacy Policy Data Protection Notice Risk Disclosure Payment Policy

© 2026 Makkler. All rights reserved. Content on this platform does not constitute investment advice.

Company news

Yahoo FinanceMar 17, 2026

CRISM Therapeutics shares jump 12% after FDA grants orphan drug status for brain cancer treatment

Shares in CRISM Therapeutics (AIM: CRTX) rose 12% to 13.4p on Tuesday after the clinical-stage drug delivery company announced the U.S. Food and Drug Administration has granted Orphan Drug Designation to its irinotecan-ChemoSeed programme for the treatment of malignant glioma. The designation...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.